ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. : revenue, balance sheet and financial ratios

ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. is a French company founded 30 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in VIGNEUX-DE-BRETAGNE (44360), this company of category PME shows in 2024 a revenue of 4.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. (SIREN 402687495)
Indicator 2024 2023 2022 2021 2020 2018
Revenue 4 648 383 € 5 038 713 € 5 932 613 € 4 926 928 € 4 306 271 € 5 012 422 €
Net income -19 310 € -655 875 € 345 003 € 517 904 € 300 102 € 206 263 €
EBITDA -484 064 € -658 841 € 353 696 € 520 973 € 420 507 € 287 752 €
Net margin -0.4% -13.0% 5.8% 10.5% 7.0% 4.1%

Revenue and income statement

In 2024, ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. achieves revenue of 4.6 M€. Activity remains stable over the period (CAGR: -1.2%). Slight decline of -8% vs 2023. After deducting consumption (992 k€), gross margin stands at 3.7 M€, i.e. a rate of 79%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -484 k€, representing -10.4% of revenue. Positive scissor effect: EBITDA margin improves by +2.7 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -19 k€ (-0.4% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

4 648 383 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

3 656 820 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-484 064 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-529 217 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-19 310 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-10.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 215%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

214.938%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

23.225%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-0.398%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-126.182

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.8%

Solvency indicators evolution
ADVANCED MEDICAL SOLUTIONS (NANTES) SAS.

Sector positioning

Debt ratio
214.94 2024
2022
2023
2024
Q1: 1.92
Med: 18.86
Q3: 55.42
Average

In 2024, the debt ratio of ADVANCED MEDICAL SOLUTION... (214.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
23.23% 2024
2022
2023
2024
Q1: 24.8%
Med: 50.27%
Q3: 69.09%
Average -15 pts over 3 years

In 2024, the financial autonomy of ADVANCED MEDICAL SOLUTION... (23.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-126.18 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.3 years
Q3: 1.74 years
Excellent -53 pts over 3 years

In 2024, the repayment capacity of ADVANCED MEDICAL SOLUTION... (-126.18) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 234.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

234.36

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-1.067

Liquidity indicators evolution
ADVANCED MEDICAL SOLUTIONS (NANTES) SAS.

Sector positioning

Liquidity ratio
234.36 2024
2022
2023
2024
Q1: 159.64
Med: 253.69
Q3: 429.69
Average -29 pts over 3 years

In 2024, the liquidity ratio of ADVANCED MEDICAL SOLUTION... (234.36) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-1.07x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.67x
Q3: 4.96x
Average -29 pts over 3 years

In 2024, the interest coverage of ADVANCED MEDICAL SOLUTION... (-1.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 45 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 76 days. Excellent situation: suppliers finance 31 days of the operating cycle (retail model). Inventory turnover is 131 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 170 days of revenue, i.e. 2.2 M€ to permanently finance. Over 2018-2024, WCR increased by +44%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 191 341 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

45 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

76 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

131 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

170 j

WCR and payment terms evolution
ADVANCED MEDICAL SOLUTIONS (NANTES) SAS.

Positioning of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Valuation estimate

Based on 57 transactions of similar company sales (all years), the value of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. is estimated at 1 054 255 € (range 489 965€ - 2 205 849€). The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
57 tx
489k€ 1054k€ 2205k€
1 054 255 € Range: 489 965€ - 2 205 849€
NAF 5 all-time

Valuation method used

Revenue Multiple
4 648 383 € × 0.23x = 1 054 255 €
Range: 489 966€ - 2 205 850€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about ADVANCED MEDICAL SOLUTIONS (NANTES) SAS.

What is the revenue of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. ?

The revenue of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. in 2024 is 4.6 M€.

Is ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. profitable?

ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. recorded a net loss in 2024.

Where is the headquarters of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. ?

The headquarters of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. is located in VIGNEUX-DE-BRETAGNE (44360), in the department Loire-Atlantique.

Where to find the tax return of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. ?

The tax return of ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. operate?

ADVANCED MEDICAL SOLUTIONS (NANTES) SAS. operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.